{"name":"Alpha-9 Oncology USA Inc.","slug":"alpha-9-oncology-usa-inc","ticker":"","exchange":"","domain":"alpha9oncologyusa.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNZUVTUC12NE94cjk0elRsd1dyQ1dQR1EwZjRPVERYUzMtamVMc25XdUNpN2ktdXEyRUk2OWIzUVRhY2FIUEUxUTB6bzhNek03U0ljS2x6d1BmUnBGWU13U2dWQkRpRktpamU4aDNWWWdWbE5wRE8tWnVaRXJQY0J1Z2hudGxRRkdhN3pvUVRWMlZ3VFk5emdkRk92enQ0VElXOFVjcE12c2NWUjV2RldoLWd5Zkp5Z2FwZVZGdWlXdmtma2I0dTR5NVRJZjFWQWZidnd5Nkh3S28xRm9ROFB5TXRGak8wNWZpMjFvbW5GV0tjZmw3?oc=5","date":"2026-01-09","type":"pipeline","source":"TradingView","summary":"Aktis Oncology, Clinical-Stage Radiopharmaceutical Oncology, Files for Nasdaq Global Select Market IPO - TradingView","headline":"Aktis Oncology, Clinical-Stage Radiopharmaceutical Oncology, Files for Nasdaq Global Select Market IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxOMFU2cmJtSjU3RXJfd1lWLWw5aHAwUmN4MGtXTnkxQ1FjX3hDRVlOMTFYQVUtM0hSSFFEbktMelVIZlZYTjI3c1FUTzJEY045ODdWb3RIQl80WnpOeW9VMm5CRUNodF9COEx3SFRPUDByOGM1WkdzTWdObGpZdUhERWpqR3REX2ktVm5zMDYxTXZuMUxOR0VfQ1VEV2NUbGNudGZvV3NHZWdXWTJYSWJGYS1XMUV5eldnUUtDc0FnRXgyTXd5X1M1b0ZtTHljcG80RE1sWkNXbGhmRmpOMmtYSUdoOFhVRFpsazFMMHFfSkRQUQ?oc=5","date":"2025-12-04","type":"trial","source":"PR Newswire","summary":"Alpha-9 Oncology Announces First Patient Dosed in Phase 1 Study of A9-3408 for the Treatment of Melanoma - PR Newswire","headline":"Alpha-9 Oncology Announces First Patient Dosed in Phase 1 Study of A9-3408 for the Treatment of Melanoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOcWlNVDh0bnpKUXVCRF93VWlzUkFWVzA4aWZfMW1hVkVYT0xaeDV0VVlaa3pSY1g0Wjk1azRYa0ZMaV9jLW9tTHVhWG00RGo2NjJlbjhKUzNYbURLNHZiNXFFLWt0cEVROVg0V25Rbk9FaWtyaldrVmpoU1diUzhDbzQ1eGg2Z0M5V0lvc0xfN09EOHJRWEZCZFNNdkxQYUdlSWhEMXZfSQ?oc=5","date":"2025-11-14","type":"pipeline","source":"Fierce Biotech","summary":"Chutes & Ladders—Ovid eyes next chapter with CEO transition - Fierce Biotech","headline":"Chutes & Ladders—Ovid eyes next chapter with CEO transition","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPTUlDazlhcl9YTHJKbTRUeWJDWmZYRDhBRWIxa0szeEVDMVNtY1dRcUNIaGZBNDVYdC1WcmZvUkJWSnlJN3dEWDZ1UjFaOVVKYkNQM0E0blc4aWZlaUYtTG1JZVpKR0o5cHF5VGNBMUI2b0RvOFpHQ3hXYWV2QzVxQzZTS0kyMmRXLTRGQW9RRVYtQnJyUUVmaU14Mjc1TXl1dUVlQk1lZDlWbkxoQVQ3QzdFMzZrUVVpeDBxSUQxU0JCUEU?oc=5","date":"2025-11-10","type":"pipeline","source":"PR Newswire","summary":"Alpha-9 Oncology Appoints Paul Blanchfield as Chief Executive Officer - PR Newswire","headline":"Alpha-9 Oncology Appoints Paul Blanchfield as Chief Executive Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOX1lPYnRTNkxEbDNyNWRJeFRtVTVscjNzMmtXZWc0NER4QVJHbkRYOVEtcDBvZUptMTF0QWR3eWh4Rmo4Y3ZuRmg0QlVzU3J3cXlqblhuRDg1bWVTY3hJamVWVTdTQ1JYSkpiVkYycW5lR3JlT2xMUmRNZ2RfWV9uMEh0UHNVZGRXcTB6aU0tb3d1U0lncFdOamtpSFVGUGc4Snc?oc=5","date":"2025-07-06","type":"trial","source":"fortune.com","summary":"Isomorphic Labs has grand ambitions to 'solve all diseases' with AI. Now, it's gearing up for its first human trials - fortune.com","headline":"Isomorphic Labs has grand ambitions to 'solve all diseases' with AI. Now, it's gearing up for its first human trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE44YzZxSzExei1pQmg2Znh0eUEzR3h0UTlNNXVySGxiTnctSUd6VEtLWG9yWkMtN2lfcmxDc1dUbmtZR0xWTjB4cDRUY1JibWZXT2p2bmVFR2daVGgtSGk4?oc=5","date":"2025-06-03","type":"pipeline","source":"Nature","summary":"The landscape for radioligand therapies in oncology - Nature","headline":"The landscape for radioligand therapies in oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNNllSZ1k5SVVyazZ5RGNScklJOGczaXltUTRwcFhHVU9acjV5T1p0U0JoNFNoSnFSRzRaWkhpV0tBeWR1TWNhTFVQUTRfVVpyOXdxZFBOLVQtbk9lN0JJckFPMzRKNU81dTlaRjBGRkVQZ2lpSVY2OTltSHVMcGw5UnBldGJKRzJjc0xqYWRhOE9SaXQ0WmdmbU9xS1g?oc=5","date":"2025-03-03","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in February 2025 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in February 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOTG5ESW1BTXhONEM5elNJYzl4ZUwxZjUzUm14UEV5cGMwM3JBRDBEWHpUNkU4NzdmTnZOSzZQSWE2OGVsbEt4b2ZwbEk2ak5rZkdKNXVrUGlGQ0hQMER0LVY1eF91aFRFQVZNczZfMWw1c0d6WC1DWGw5M2ZmWlZrWmxYdVNMeXhRRzBGRE50eDQ2TEQ3dVlKZEM5TlR3Q0hQUHhRa0VvU0xOVGtsQlI0ZDZNMHdMc0w5?oc=5","date":"2024-10-24","type":"pipeline","source":"Pharmaceutical Technology","summary":"Alpha-9 becomes latest radiopharma to secure funds with $175m Series C - Pharmaceutical Technology","headline":"Alpha-9 becomes latest radiopharma to secure funds with $175m Series C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQb3c5UHdzUU85YVpSUjFISmVWQmwwTDlhZzdVQzJJLS0wNDl3ZlBwb1FQcC10NHJhSnNEbVl1ZXFPVVlSOGVPTDlab1hXQm5VLWNwVnFxV29BVmJMUGpuckVCTnZOdFJSTlZuLVB4dDJTbUVLMHRKS3pyWmxvc2Z1UE5jNUpHMXp0QVJzOVQ2R0o2VFpxUUxEY1NNTXNGbEhOR1dR?oc=5","date":"2024-10-24","type":"pipeline","source":"The Pharma Letter","summary":"Radiopharma start-up Alpha-9 Oncology secures $175 million | Pharmaceutical | The Pharmaletter - The Pharma Letter","headline":"Radiopharma start-up Alpha-9 Oncology secures $175 million | Pharmaceutical | The Pharmaletter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxORnhRMnJYdi1CRkN6TWlMY2NEcTJPTVVpX2hVWnRmb2dlV1hCWGx2YXJfRzFHd0JPRDV4UktnTlY5dVBYZWkzS1gzblhlWmRNZUpoYWxvR1R5SlR5Rjk3ZUEzVVpEekJRZmVJYk85TjFDRHhlLTdXbXp2TE5lVVJ6c2ptdG5selVZSE05TWoydjJNcjhyajdIeW16d1RCQktPNlpiM2QxZzBrblJp?oc=5","date":"2024-10-23","type":"pipeline","source":"Fierce Biotech","summary":"Alpha-9 raises $175M series C to bankroll clinical-stage radiopharma pipeline - Fierce Biotech","headline":"Alpha-9 raises $175M series C to bankroll clinical-stage radiopharma pipeline","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxPQVFzaEtxa0hqTF96eTJiTWFZamYzMUtEcDR6ZktYcDZOckNoV1ZlclhWTmdYNUp6OFNTY2tyQ3AtT0p6cVE3WnlaZGFXcUd3bU9lMVJiZldWcV9HN0ViMWRxSUY1VUZIalpZcGRjOXdwa1lsb2JPZi1EVW9TaDZubk9qMFVfWDRNRTV2aU1CLTNKUnVrWGZidWl3Vnp5T0s5OWJjdmNROXJQVk5KZG9VazZyTTRUR1FTaXptLW1zTktVOXJDcEZJYk5MTjU0dkJiS2laQkxtWk1fV19kSVI1di1JUUhCQzN4emxCT1FBZ2ZtM18xaDRJc1dqejRBNDJLbW9SSHZxbzNOUXM?oc=5","date":"2024-01-08","type":"pipeline","source":"Business Wire","summary":"NorthStar Medical Radioisotopes and Alpha-9 Oncology Enter Strategic Long-term Agreement for Supply of Actinium-225 (Ac-225) - Business Wire","headline":"NorthStar Medical Radioisotopes and Alpha-9 Oncology Enter Strategic Long-term Agreement for Supply of Actinium-225 (Ac-","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}